RGS RGS Healthcare Solutions

European market guides

How healthcare tenders work, market by market

Each European country buys medicines and medical devices differently. These guides explain who buys in each market, through which procurement route, what tends to decide awards, and what is published and what is not. All 27 EU countries are refreshed daily in the platform, together with the UK, Norway and Switzerland.

Choose a market

Country guides

Select a country on the map or from the list. Markets without a dedicated guide are still covered in full in the platform.

RGS covers what buyers publish. Some prices are never published anywhere, such as insurer discounts and negotiated hospital deals; for those we set up a private pipeline with your own bids, results and price lists, visible only to your team.

At a glance

Who buys, and how, by market

MarketMain buyersMain routes
GermanyStatutory health insurers (AOK, TK, BARMER, DAK, IKK and BKK groups); hospital purchasing groups; public university and municipal hospitalsDiscount contracts (Rabattverträge) for outpatient generics and biosimilars; hospital tenders and purchasing-group contracts; open-house contracts that any supplier can join
FranceUniHA, Resah and AGEPS (AP-HP); regional hospital groups (GHT); UGAP for some categoriesFramework agreements (accords-cadres) and marchés by lot, often national in scope; regional GHT tenders
ItalyRegional central purchasing bodies (for example ARIA, SoReSa, Intercent-ER, ESTAR, Azienda Zero); local health authorities and hospitals below the thresholdRegional tenders by lot; framework agreements (accordo quadro), which for biosimilars include several ranked suppliers
SpainINGESA (national centralised purchasing); regional health services such as SAS, SERMAS, CatSalut and ICS, Osakidetza and SERGAS; individual hospitalsNational framework agreements, for example for biosimilars; regional and hospital tenders by lot
NetherlandsHealth insurers for outpatient medicines; hospitals and hospital purchasing groups for inpatient and specialist medicinesInsurer preference policy (selection rounds, not public tenders); university hospital tenders; negotiated hospital contracts
BelgiumIndividual hospitals and loco-regional hospital networks; joint tenders between hospitalsHospital tenders by lot and framework agreements
United KingdomNational NHS commercial teams (the Commercial Medicines Unit) for hospital medicines; NHS Supply Chain for devices and consumables; NHS National Services Scotland; NHS Wales Shared Services PartnershipNational generics and biosimilar frameworks in waves, split by region; device frameworks
NordicsAmgros (Denmark); Sykehusinnkjøp HF (Norway); the Swedish regions, often jointly by healthcare region; Finnish wellbeing services counties and their joint purchasing unitsNational or regional hospital tenders by product; joint Nordic tenders for off-patent hospital medicines; Sweden's pharmacy generics follow a monthly lowest-price system
Austria and SwitzerlandAustria: the state hospital operators and the Bundesbeschaffung GmbH (BBG) for selected medicines. Switzerland: cantonal and university hospitals and their purchasing groupsAustria: open tenders and many negotiated procedures. Switzerland: hospital tenders by lot under the revised federal and cantonal procurement rules
Portugal, Ireland and GreecePortugal: SPMS and the 39 local health units (ULS) formed in 2024. Ireland: the Health Service Executive. Greece: EKAPY and public hospitalsPortugal: central framework agreements and ULS tenders. Ireland: a dynamic purchasing system for authorised medicines. Greece: central EKAPY tenders and negotiations
Central and Eastern EuropeIndividual public hospitals; national central purchasing in Romania and Hungary; the health insurers in Czechia from 2026Hospital tenders by lot; dynamic purchasing systems; national framework agreements

New to European medicine tenders? Start with how pharmaceutical tenders work in Europe , see the main medicine buyers per market or read what the Critical Medicines Act would change

Buyer structures change. These guides describe the main routes as of 2026; the platform tracks individual buyers and notices continuously.

Track these markets on one calendar

The calendar, award database and pricing model cover Europe in a single view.